OB/GYN Latest | Physician's Weekly

OB/GYN Latest 2 days ago

Biosimilars Could Cut Spending for Biologic Therapy in the U.S.

FRIDAY, Jan. 21, 2022 (HealthDay News) -- Biosimilar drugs could drive down prices for biologic drugs and generate savings of about $38.4 billion between 2021 and 2025, according to a study publish...

Predictors of Medication Initiation and Retention in Treatment for Opioid Use Disorder in Pregnant Women in the United States, 2013–2017
A Wireless Self-Guided Fatal Heart Rate Monitor's Accuracy, Clinical Utility, and Usability
Recommendations Updated for Recombinant Zoster Vaccine
Long-Term Outcomes Described for Survivors of Childhood ALL

Claim Your Free Staff Education Wallboard!

Please select specialty

OB/GYN Latest 2 days ago

Biosimilars Could Cut Spending for Biologic Therapy in the U.S.

Predictors of Medication Initiation and Retention in Treatment for Opioid Use Disorder in Pregnant Women in the United States, 2013–2017

A Wireless Self-Guided Fatal Heart Rate Monitor's Accuracy, Clinical Utility, and Usability

Recommendations Updated for Recombinant Zoster Vaccine

Long-Term Outcomes Described for Survivors of Childhood ALL

SUB SPECIALTIES

Claim Your Free
Staff Education Wallboard!